Qyuns Therapeutics Co., Ltd. (HKG:2509)
Hong Kong · Delayed Price · Currency is HKD 16.97
+0.19 (1.13%)
Aug 21, 2026, 3:45 PM HKT
Qyuns Therapeutics Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 325.09 | 961.75 | 360.69 | 216.3 | 213.09 | 218.06 |
Short-Term Investments | 269.17 | 80.86 | 0.42 | 0.54 | 0.55 | 0.29 |
Trading Asset Securities | 421.44 | - | 195.44 | 160.41 | 401.1 | 402.38 |
Cash & Short-Term Investments | 1,016 | 1,043 | 556.55 | 377.26 | 614.73 | 620.72 |
Cash Growth | 81.73% | 87.33% | 47.53% | -38.63% | -0.97% | - |
Accounts Receivable | 251.73 | 19.7 | 26.28 | - | - | - |
Other Receivables | - | 0.18 | 0.6 | 0.36 | 4.04 | 8.65 |
Receivables | 251.73 | 19.87 | 26.88 | 0.36 | 4.04 | 8.65 |
Inventory | 63.95 | 8.45 | 3.34 | 3.77 | - | - |
Prepaid Expenses | - | 16.13 | 24.52 | 23.03 | 16.23 | 18.45 |
Other Current Assets | - | 29.61 | 5.44 | 13.91 | 0.94 | 0.44 |
Total Current Assets | 1,333 | 1,117 | 616.73 | 418.33 | 635.95 | 648.26 |
Property, Plant & Equipment | 305.83 | 309.83 | 334.06 | 361.44 | 386.16 | 400.83 |
Long-Term Investments | 233.07 | 134.86 | - | - | - | - |
Other Intangible Assets | 2.06 | 2.46 | 3.47 | 2.35 | 3.05 | 0.38 |
Other Long-Term Assets | 36.58 | 36.51 | 29.62 | 13.47 | 9.94 | 18.02 |
Total Assets | 1,911 | 1,600 | 983.88 | 795.58 | 1,035 | 1,067 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 284.47 | 96.72 | 110.89 | 72.96 | 19.14 | 12.6 |
Accrued Expenses | - | 43.79 | 33.37 | 31.01 | 24.64 | 19.04 |
Short-Term Debt | - | 29.8 | 179.48 | 59.6 | 15.9 | - |
Current Portion of Long-Term Debt | 213.68 | 148.15 | 31.1 | 60.1 | 44.61 | 14.87 |
Current Portion of Leases | 0.95 | 1.27 | 1.42 | 1.29 | 1.75 | 0.96 |
Current Unearned Revenue | 79.24 | 44.53 | 9.36 | 0.87 | - | - |
Other Current Liabilities | 3.13 | 139.48 | 64.54 | 25.95 | 16.15 | 22.22 |
Total Current Liabilities | 581.48 | 503.74 | 430.16 | 251.78 | 122.19 | 69.67 |
Long-Term Debt | 470.84 | 399.45 | 315.12 | 224.43 | 232.52 | 274.05 |
Long-Term Leases | 1.03 | 1.34 | 0.47 | 0.63 | 0.47 | 0.39 |
Long-Term Unearned Revenue | 16.03 | 16.44 | 16.73 | 17.38 | 18.02 | 18.66 |
Long-Term Deferred Tax Liabilities | 0.23 | 0.27 | 0.34 | 0.41 | 0.49 | 0.56 |
Total Liabilities | 1,070 | 921.23 | 762.83 | 494.63 | 373.69 | 363.33 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 227.07 | 227.07 | 222.07 | 210.03 | 180.53 | 166.48 |
Additional Paid-In Capital | - | 1,098 | 1,012 | 830.18 | 830.18 | 616.23 |
Retained Earnings | - | -942.48 | -1,257 | -921.36 | -413.61 | -115.42 |
Treasury Stock | - | -27.19 | - | - | - | - |
Comprehensive Income & Other | 633.95 | 338.2 | 251.37 | 175.91 | 44.62 | 3.06 |
Total Common Equity | 861.02 | 694.03 | 228.98 | 294.76 | 641.72 | 670.35 |
Minority Interest | -19.68 | -14.93 | -7.93 | 6.19 | 19.7 | 33.82 |
Shareholders' Equity | 841.35 | 679.1 | 221.05 | 300.95 | 661.41 | 704.17 |
Total Liabilities & Equity | 1,911 | 1,600 | 983.88 | 795.58 | 1,035 | 1,067 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 686.51 | 580.01 | 527.6 | 346.06 | 295.25 | 290.26 |
Net Cash (Debt) | 329.19 | 462.6 | 28.96 | 31.2 | 319.48 | 330.46 |
Net Cash Growth | - | 1497.61% | -7.18% | -90.23% | -3.32% | - |
Net Cash Per Share | 1.45 | 2.07 | 0.13 | 0.15 | 1.80 | 2.84 |
Filing Date Shares Outstanding | 223.42 | 225.56 | 222.07 | 222.07 | 180.53 | 166.48 |
Total Common Shares Outstanding | 223.42 | 225.56 | 222.07 | 210.03 | 180.53 | 166.48 |
Working Capital | 751.94 | 612.93 | 186.56 | 166.55 | 513.76 | 578.59 |
Book Value Per Share | 3.85 | 3.08 | 1.03 | 1.40 | 3.55 | 4.03 |
Tangible Book Value | 858.96 | 691.57 | 225.5 | 292.42 | 638.66 | 669.98 |
Tangible Book Value Per Share | 3.84 | 3.07 | 1.02 | 1.39 | 3.54 | 4.02 |
Buildings | - | 238.61 | 238.61 | 238.73 | 238.73 | 238.73 |
Machinery | - | 195.06 | 190.77 | 188.24 | 178.24 | 168.09 |
Construction In Progress | - | 0.07 | 0.43 | 0.21 | 4.96 | 2.01 |